You are now viewing 1 - 5 of 5 results
January 1, 2010 | Journal Article
The medical profession and pharmaceutical industry have fallen short in reducing the influence of gifts on prescription practices through self-regulation. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession.
June 21, 2012 | Journal Article
Biomarkers may prove important in medicine, but controversy about biomarker patents has increased in recent years.
September 1, 2011 | Journal Article
Using market exclusivity to promote pharmaceutical innovation can lead to positive outcomes, but the practice is also characterized by waste and collateral effects.
May 1, 2013 | Journal Article
A harm-reduction model where the marketing is handled by a nonprofit entity is needed to align with the goals of reducing tobacco-related harm.
August 1, 2003 | Program Result Report
In this 2000–2001 project, Linda Bergthold, PhD, and researchers at Stanford University, Stanford, Calif., surveyed health plan medical directors in 48 states about medical necessity decision making. The study provides input for policy-making at the state and national levels.